𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rituximab Therapy for Refractory Thrombotic Thrombocytopenic Purpura

✍ Scribed by Lorence A. Gutterman; Bruce Kloster; Han-Mou Tsai

Book ID
115590239
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
69 KB
Volume
28
Category
Article
ISSN
1079-9796

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rituximab for treatment of refractory/re
Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP)
✍ Afaq Ahmad; Anita Aggarwal; Daya Sharma; Harish P. Dave; Virginia Kinsella; Marg πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 2 views

## Abstract Plasma exchange is the standard treatment for thrombotic thrombocytopenic purpura (TTP). For patients refractory to plasma exchange, treatment options are limited and often unsuccessful. The platelet thrombi that form in acquired TTP are believed to result from the presence of procoagul

Successful repeat therapy with rituximab
Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura
✍ Wilmar Patino; Ravindra Sarode πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 141 KB

## Abstract Thrombotic thrombocytopenic purpura (TTP) is a life‐threatening disease that is treated successfully with therapeutic plasma exchange (TPE) and often with corticosteroids; however, almost one third of TTP patients have treatment failures that require either long‐term TPEs or other adjun